A Look Ahead: Bio-Techne's Earnings Forecast

Bio-Techne (NASDAQ:TECH) will release its quarterly earnings report on Wednesday, 2024-10-30. Here's a brief overview for investors ahead of the announcement.

Analysts anticipate Bio-Techne to report an earnings per share (EPS) of $0.38.

Investors in Bio-Techne are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.

It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.

Earnings History Snapshot

Last quarter the company missed EPS by $0.00, which was followed by a 3.4% increase in the share price the next day.

Here's a look at Bio-Techne's past performance and the resulting price change:

Quarter

Q4 2024

Q3 2024

Q2 2024

Q1 2024

EPS Estimate

0.49

0.45

0.41

0.44

EPS Actual

0.49

0.48

0.40

0.41

Price Change %

3.0%

3.0%

-4.0%

-3.0%

Analyst Insights on Bio-Techne

For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Bio-Techne.

Analysts have provided Bio-Techne with 3 ratings, resulting in a consensus rating of Buy. The average one-year price target stands at $82.33, suggesting a potential 16.98% upside.

Comparing Ratings with Peers

The analysis below examines the analyst ratings and average 1-year price targets of Medpace Hldgs, Charles River and Bio-Rad Laboratories, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.

Medpace Hldgs received ...